Celldex Therapeutics Files 8-K on Director Changes and Shareholder Votes
Ticker: CLDX · Form: 8-K · Filed: Jun 6, 2025 · CIK: 744218
| Field | Detail |
|---|---|
| Company | Celldex Therapeutics, Inc. (CLDX) |
| Form Type | 8-K |
| Filed Date | Jun 6, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: governance, officer-compensation, shareholder-vote
Related Tickers: CDLX
TL;DR
Celldex 8-K: Director shuffle, new exec pay, and shareholder votes are on the table.
AI Summary
Celldex Therapeutics, Inc. filed an 8-K on June 6, 2025, reporting on several key events. These include the departure of a director, the election of new directors, and updates to compensatory arrangements for certain officers. The filing also covers the submission of matters to a vote of security holders and includes financial statements and exhibits.
Why It Matters
This filing provides crucial updates on the company's governance and potential shareholder decisions, which can impact investor confidence and strategic direction.
Risk Assessment
Risk Level: medium — Changes in directorships and executive compensation can signal internal shifts or strategic realignments that may carry inherent business risks.
Key Players & Entities
- Celldex Therapeutics, Inc. (company) — Registrant
- June 5, 2025 (date) — Earliest event reported date
- June 6, 2025 (date) — Filing date
FAQ
Who has departed from Celldex Therapeutics' board of directors?
The filing indicates the departure of a director, but the specific name is not detailed in the provided text.
Were any new directors elected to the board?
Yes, the filing states that new directors were elected.
What other items are covered in this 8-K filing?
The filing also covers updates to compensatory arrangements of certain officers, submission of matters to a vote of security holders, and includes financial statements and exhibits.
What is the state of incorporation for Celldex Therapeutics, Inc.?
Celldex Therapeutics, Inc. is incorporated in Delaware.
When was the earliest event reported in this filing?
The earliest event reported in this filing occurred on June 5, 2025.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 6, 2025 regarding Celldex Therapeutics, Inc. (CLDX).